Cargando…
1274. Evaluating the Activity of SPR719, a Novel Aminobenzimidazole, against Nontuberculous Mycobacteria
BACKGROUND: Pulmonary infections caused by Nontuberculous Mycobacteria (NTM) are increasing in prevalence and are associated with high mortality and morbidity. Members of the Mycobacterium avium complex (MAC; primarily M. avium and M. intracellulare) and M. abscessus are most commonly associated wit...
Autores principales: | Murray, Beverly, Hall, Danielle, Cotroneo, Nicole S, Critchley, Ian, Pucci, Michael, Stokes, Suzanne, Pillar, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777383/ http://dx.doi.org/10.1093/ofid/ofaa439.1458 |
Ejemplares similares
-
In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2022) -
In Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance
por: Kim, Dae Hun, et al.
Publicado: (2024) -
1659. Pharmacokinetics/pharmacodynamics of the Novel Gyrase Inhibitor SPR719/SPR720 and Clinical Dose Selection to Treat Pulmonary Mycobacterium avium-complex Disease
por: Deshpande, Devyani, et al.
Publicado: (2020) -
Nontuberculous Mycobacteria from Household Plumbing of Patients with Nontuberculous Mycobacteria Disease
por: Falkinham, Joseph O.
Publicado: (2011) -
Nontuberculous Mycobacteria, Zambia
por: Buijtels, Patricia C.A.M., et al.
Publicado: (2009)